Financials
- Market Capitalization 756.67 M
- Employee 61
- Founded 2006
- CEO N/A
- Website www.zevra.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG1F5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
4.64
Fiyat/satışlar oranı
4.39
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2597 | REPL Replimune Group, Inc. - Common Stock | 9.68 USD | -1.93% | -12.24% | +8.76% | -26.61% | 812.59 M USD | ||
| 2621 | CTMX CytomX Therapeutics, Inc. - Common Stock | 3.57 USD | -2.46% | -3.51% | +17.82% | +48.75% | 777.20 M USD | ||
| 2638 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 40.70 USD | -1.14% | -3.21% | +21.35% | +35.08% | 753.03 M USD | ||
| 2640 | OMER Omeros Corporation - Common Stock | 10.49 USD | -0.10% | -1.59% | +12.31% | +188.98% | 759.22 M USD |